This is an open-label, multicenter, extension trial to evaluate the long term safety and efficacy of RPC1063 in patients with moderately to severely active ulcerative colitis (UC). Patients who have previously participated in a trial of RPC1063 for UC will be eligible for entry in this trial if they meet the eligibility criterion for participation as outlined in the prior trial.
A Collaboration of the San Antonio Bioscience and Medical Research Community
A first-of-its-kind initiative between public and private sector to catalog and highlight Bioscience research in the city of San Antonio and the surrounding areas.
